Compound information
- Natural Products
- ZC710942
- Molecular Formula
- C16H22N2O6S
- Molecular Weight
- 370.119857424 g/mol
- Structure
-
- IUPAC Name
- 4-(4-tert-butoxycarbonylpiperazin-1-yl)sulfonylbenzoic acid
- InChI
- InChI=1S/C16H22N2O6S/c1-16(2,3)24-15(21)17-8-10-18(11-9-17)25(22,23)13-6-4-12(5-7-13)14(19)20/h4-7H,8-11H2,1-3H3,(H,19,20)
- InChI Key
- BXAHCUDDQZXTCY-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccc(C(=O)O)cc2)CC1
- Source
- ZINC000013461372
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 104.22 Å2 | LogP | 2.25 |
LogS | -3.437 | LogD | 1.463 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.005 | Pgp substrate | 0.053 |
HIA | 0.961 | F20 % | 0.675 |
F30 % | 0.657 | Caco-2 | -5.123 |
MDCK | -5.417 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.109 | PPB | 85.727 |
VD | 0.735 | Fu | 0.569 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.018 | CYP1A2 substrate | 0.36 |
CYP2A6 substrate | 0.474 | CYP2B6 substrate | 0.576 |
CYP2C19 inhibitor | 0.055 | CYP2C19 substrate | 0.686 |
CYP2C8 substrate | 0.534 | CYP2C9 inhibitor | 0.047 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.013 |
CYP2D6 substrate | 0.459 | CYP2E1 substrate | 0.762 |
CYP3A4 inhibitor | 0.005 | CYP3A4 substrate | 0.958 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.739 | CL | 4.44 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.337 | Hepatotoxicity | 0.558 |
Mutagenicity | 0.023 | Rat Oral Acute Toxicity | 0.019 |
FDAMDD | 0.009 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.086 | Eye Corrosion | 0.001 |
Eye Irritation | 0.045 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.762 | IGC50 | 2.14 |
LC50FM | 0.744 | LC50DM | 2.099 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.277 | NR-AR-LBD | 0.285 |
NR-AhR | 0.031 | NR-Aromatase | 0.039 |
NR-ER | 0.237 | NR-ER-LBD | 0.431 |
NR-PPAR-gamma | 0.183 | SR-ARE | 0.231 |
SR-ATAD5 | 0.345 | SR-HSE | 0.061 |
SR-MMP | 0.011 | SR-p53 | 0.042 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.